Welcome to our dedicated page for Marex Group SEC filings (Ticker: MRX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Marex Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Marex Group's regulatory disclosures and financial reporting.
Myers Linda Kristine reported acquisition or exercise transactions in this Form 4 filing.
Marex Group plc director Linda Kristine Myers reported receiving an equity grant of 2,070 restricted share awards of Ordinary Shares on June 9, 2026 at no cash cost per share. Each award is a contingent right to one ordinary share upon vesting and settlement. Following this grant, she directly holds 23,214 Ordinary Shares, reflecting routine share-based compensation rather than an open-market purchase.
Pickering Robert Mark reported acquisition or exercise transactions in this Form 4 filing.
Marex Group plc director Robert Mark Pickering received an equity grant of 2,070 ordinary shares in the form of restricted share awards. The grant was made at no cash cost per share and increases his direct holdings to 31,766 ordinary shares, including the unvested awards that will deliver one share per award upon vesting.
Marex Group plc has completed an offering of U.S.$500 million perpetual subordinated resettable fixed rate notes, described as hybrid perpetual securities. The notes are expected to receive 100% equity credit from S&P following Marex’s proposed Bermuda redomiciliation.
Marex intends to use the net proceeds for general corporate purposes, including funding the purchase of any or all of its outstanding U.S.$100,000,000 13.250% fixed rate reset perpetual subordinated contingent convertible notes via a tender offer announced on 1 June 2026 and for acquisitions. The new notes are priced at 7.7%, compared to the previous AT1 issuance at 13.25%, which management highlights as evidence of progress and investor confidence.
Marex Group plc submitted an SEC insider filing for director Assi Georges. The provided data shows no reported transactions in company securities and no listed derivative positions or holdings, indicating this filing is purely informational with respect to this insider’s status.
Marex Group plc has appointed fintech entrepreneur and investment banker Georges Assi to its Group Board, effective immediately. He will serve as a member of the Board’s Risk Committee, adding experience in credit, fixed income and technology-enabled lending.
Assi is CEO of Sigma Lending, a UK fintech lender he founded in 2023, and Co‑Founder and Partner of Naviter Capital, an investment firm focused on private credit markets. He previously held senior roles at Nomura International and Lehman Brothers. The company notes that the explanatory information in this report is incorporated by reference into its existing Form S‑8 and Form F‑3 registration statements.
Marex Group plc officer Thomas Texier reported selling 1,572 Ordinary Shares of MRX in open-market transactions under a pre-arranged Rule 10b5-1 trading plan. The shares were sold at weighted average prices in the low-$50s per share.
After these sales, Texier directly holds 207,019 Ordinary Shares, which includes 150,563 shares underlying deferred bonus plan awards that will be delivered upon vesting and settlement.
Marex Group plc priced a $2,000,000 offering of Autocallable Fixed Income Barrier Notes due December 8, 2027, sold at $1,000 per Note. The Notes pay a monthly fixed Interest Payment of 1.334% (equivalent to 16.008% per annum) and are callable monthly beginning with observation dates on or after September 1, 2026.
The Notes reference the worst performing of ONON, UBS and AVGO, return principal at maturity unless the Worst Performing Underlying declines by more than 50.00%, and otherwise provide full downside exposure to that Worst Performing Underlying. Payments are subject to Marex credit risk; the Estimated Initial Value on the Trade Date was $963.40 per Note, which is less than the price to public.
Marex Group plc director Linda Kristine Myers reported a routine tax-related share disposition. On June 1, 2026, 1,115 ordinary shares were withheld to cover tax obligations tied to vesting of previously reported restricted share awards, using a reference price of $52.94 per share. After this withholding, she directly holds 21,144 ordinary shares.
Marex Group plc director John W. Pietrowicz reported a routine tax-related share disposition. In connection with the vesting of previously reported restricted share awards, 558 ordinary shares were withheld to satisfy tax obligations, using a reference price of $52.94 per share. After this withholding, he directly holds 21,701 ordinary shares, and no open-market buy or sell transaction occurred.
Marex Group plc director Sarah Ing reported routine share movements. The filing shows 1,310 Ordinary Shares were disposed of to cover a tax withholding obligation linked to the vesting of previously reported restricted share awards, at a reference price of $52.94 per share.
After this tax-withholding disposition, Ing holds 8,825 Ordinary Shares directly and 535 Ordinary Shares indirectly through her spouse. The transaction reflects compensation-related tax settlement rather than an open-market purchase or sale.